A Role for the Serotonin Transporter in the Largely Unknown Molecular Pathophysiology of Premenstrual Dysphoric Disorder

被引:0
|
作者
Meyer, Jeffrey H. [1 ,2 ,3 ,4 ]
机构
[1] Ctr Addict & Mental Hlth, Brain Hlth Imaging Ctr, Toronto, ON, Canada
[2] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
BINDING;
D O I
10.1016/j.biopsych.2023.04.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:1054 / 1055
页数:2
相关论文
共 50 条
  • [41] Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR
    Gingnell, Malin
    Comasco, Erika
    Oreland, Lars
    Fredrikson, Mats
    Sundstrom-Poromaa, Inger
    ARCHIVES OF WOMENS MENTAL HEALTH, 2010, 13 (05) : 417 - 423
  • [42] Increase in Serotonin Transporter Binding Across the Menstrual Cycle in Patients With Premenstrual Dysphoric Disorder: A Case-Control Longitudinal Positron Emission Tomography (PET) Imaging Study
    Sacher, Julia
    Hesse, Swen
    Zsido, Rachel
    Barth, Claudia
    Zientek, Franziska
    Rullmann, Michael
    Patt, Marianne
    Becker, Georg A.
    Luthardt, Julia
    Ralf, Regenthal
    Jank, Alexander
    Villringer, Arno
    Sabri, Osama
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 106 - 106
  • [43] Nociceptive Processing in Women With Premenstrual Dysphoric Disorder (PMDD) The Role of Menstrual Phase and Sex Hormones
    Bartley, Emily J.
    Palit, Shreela
    Kuhn, Bethany L.
    Kerr, Kara L.
    Terry, Ellen L.
    DelVentura, Jennifer L.
    Rhudy, Jamie L.
    CLINICAL JOURNAL OF PAIN, 2015, 31 (04): : 304 - 314
  • [44] Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty
    Hantsoo, Liisa
    Sajid, Husna
    Murphy, Laura
    Buchert, Brett
    Barone, Jordan
    Raja, Sabina
    Eisenlohr-Moul, Tory
    JOURNAL OF WOMENS HEALTH, 2022, 31 (01) : 100 - 109
  • [45] What Symptoms Trigger Symptom-Onset Serotonin Reuptake Inhibitor Treatment in Premenstrual Dysphoric Disorder? A Prospective Evaluation
    Forray, Ariadna
    Gilstad-Hayden, Kathryn
    Yonkers, Kimberly
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S376 - S376
  • [46] Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study
    Sacher, Julia
    Zsido, Rachel G.
    Barth, Claudia
    Zientek, Franziska
    Rullmann, Michael
    Luthardt, Julia
    Patt, Marianne
    Becker, Georg A.
    Rusjan, Pablo
    Witte, A. Veronica
    Regenthal, Ralf
    Koushik, Abhay
    Kratzsch, Juergen
    Decker, Beate
    Jogschies, Petra
    Villringer, Arno
    Hesse, Swen
    Sabri, Osama
    BIOLOGICAL PSYCHIATRY, 2023, 93 (12) : 1081 - 1088
  • [47] THE ROLE OF SEROTONIN AND DOPAMINE IN THE PATHOPHYSIOLOGY OF OBSESSIVE-COMPULSIVE DISORDER
    GOODMAN, WK
    MCDOUGLE, CJ
    PRICE, LH
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 7 : 35 - 38
  • [48] Risk factors for premenstrual dysphoric disorder in a community sample of young women: The role of traumatic events and posttraumatic stress disorder
    Perkonigg, A
    Yonkers, KA
    Pfister, H
    Lieb, R
    Wittchen, HU
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (10) : 1314 - 1322
  • [49] Luteal Phase Epigenetic Biomarkers Identify Premenstrual Dysphoric Disorder (PMDD) and Selective Serotonin Reuptake Inhibitor (SSRI) Response in PMDD
    Hantsoo, Liisa
    Kaminsky, Zachary
    Payne, Jennifer
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 240 - 241
  • [50] Luteal Phase Epigenetic Biomarkers Identify Premenstrual Dysphoric Disorder (PMDD) and Selective Serotonin Reuptake Inhibitor (SSRI) Response in PMDD
    Hantsoo, Liisa
    Kaminsky, Zachary
    Payne, Jennifer
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 240 - 241